Day 1 Morning: Vascular Access - Tuesday, 25th April
Venue: Admiral / Livestream 3
Time: 08:00 - 13:00
Vascular Access CX Masterclass
Time: 08:00 - 09:30
| Anchor: | Nicholas Inston, Birmingham, United Kingdom |
| Moderator: | Kate Steiner, Stevenage, United Kingdom |
08:00 - 08:05
Patient selection and procedures: A case-based look at how I’ve refined my endovascular AVF creation practice and algorithm
| Speaker: | Kate Steiner, Stevenage, United Kingdom |
08:05 - 08:10
Audience Participation & Discussion
08:10 - 08:15
How to add endovascular AVF creation to your dialysis practice
| Speaker: | Ounali Jaffer |
08:15 - 08:20
Audience Participation & Discussion
08:20 - 08:25
Novel approaches in device created fistulas. New sites? New indications?
| Speaker: | Alexandros Mallios, Paris, France |
08:25 - 08:30
Audience Participation & Discussion
08:30 - 08:35
Progress on locator directed minimally invasive fistula formation
| Speaker: | Simon Hogan, London, United Kingdom |
08:35 - 08:40
Audience Participation & Discussion
08:40 - 08:45
Is there too much evidence? Drug-eluting balloons
| Speaker: | Ounali Jaffer |
08:45 - 08:50
Audience Participation & Discussion
08:50 - 08:55
Is evidence reliable? Lessons from arteriovenous grafts
| Speaker: | David Kingsmore |
08:55 - 09:00
Audience Participation & Discussion
09:00 - 09:05
The need for more evidence: PAVE 2
| Speaker: | Narayan Karunanithy, London, United Kingdom |
09:05 - 09:10
Audience Participation & Discussion
09:10 - 09:20
Edited Case: AV revision with covered stent
| Speaker: | Daniel Patel, Daytona Beach, United States |
09:20 - 09:30
Audience Participation & Discussion
Vascular Access CX Masterclass Continued
Time: 09:30 - 10:10
| Anchor: | Kate Steiner, Stevenage, United Kingdom |
| Moderator: | Narayan Karunanithy, London, United Kingdom |
09:40 - 09:45
Going forward - Priorities in vascular access research
| Speaker: | Jonathan de Siqueira, Leeds, United Kingdom |
09:45 - 09:50
Audience Participation & Discussion
09:50 - 09:55
The evidence has been analysed: The vascular access treatment algorithm and patient-based choices
| Speaker: | Charmaine Lok, Toronto, Canada |
09:55 - 10:00
Audience Participation & Discussion
10:00 - 10:05
Edited case: EndoAVF: Creation and conversation with an experienced interventionalist
| Speaker: | Robert Shahverdyan |
10:05 - 10:10
Audience Participation & Discussion
Coffee Break
Time: 10:10 - 10:30
Sponsored Education
Time: 10:30 - 11:00
Vascular Access CX Masterclass Continued
Time: 11:00 - 13:00
| Anchor: | Nicholas Inston, Birmingham, United Kingdom |
| Moderator: | Alexandros Mallios, Paris, France |
11:00 - 11:05
Podium First: IN.PACT AV Access trial - 3 year subanalysis data
| Speaker: | Andrew Holden, Auckland, New Zealand |
11:05 - 11:10
Audience Participation & Discussion
11:10 - 11:15
ACCess Study: Anaesthesia is important
| Speaker: | Emma Aitken, Glasgow, United Kingdom |
11:15 - 11:20
Audience Participation & Discussion
11:20 - 11:25
Sirolimus for fistula maturation - The ACCESS 2 study
| Speaker: | Rajesh Sivaprakasam, London, United Kingdom |
11:25 - 11:30
Audience Participation & Discussion
11:30 - 11:35
SONAR Trial - Update
| Speaker: | Gavin Pettigrew, Cambridge, United Kingdom |
11:35 - 11:40
Audience Participation & Discussion
11:40 - 11:45
ABISS Trial
| Speaker: | Raphael Coscas, Paris, France |
11:45 - 11:50
Audience Participation & Discussion
11:50 - 11:55
Experience and indications with an access catheter system for central venous access
| Speaker: | Dirk Hentschel, Boston, United States |
11:55 - 12:00
Audience Participation & Discussion
12:00 - 12:05
Vein dilatation pre fistula formation: First-in-man trial
| Speaker: | Surendra Shenoy, St Louis, United States |
12:05 - 12:10
Audience Participation & Discussion
12:10 - 12:15
Are we ready for patient monitoring devices? - The NHS vision
| Speaker: | Rajesh Sivaprakasam, London, United Kingdom |
12:15 - 12:20
Audience Participation & Discussion
12:20 - 12:25
External support results in better outcomes and cost effectiveness
| Speaker: | Ellen Dillavou, Raleigh, United States |
12:25 - 12:30
Audience Participation & Discussion
12:30 - 12:35
Podium First: A new kind of graft
| Speaker: | Frans Moll, Utrecht, Netherlands |
12:35 - 12:40
Audience Participation & Discussion
12:40 - 12:45
High-risk FTM patients and ecAVG: Histological analysis of intensive needling
| Speaker: | Matteo Tozzi |
12:45 - 12:50
Audience Participation & Discussion
12:50 - 12:55
Optimizing the treatment for arteriovenous graft stenosis: Surveillance and procedural considerations
| Speaker: | David Kingsmore |
12:55 - 13:00
Audience Participation & Discussion
Lunch Break
Time: 13:00 - 13:30
Sponsored Education
Time: 13:30 - 14:00